| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/20/2000 | EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 09/20/2000 | EP1035864A2 Methods and compositions for the treatment of psoriasis |
| 09/20/2000 | EP1035856A1 Isolated dna encoding human h3 histamine receptor |
| 09/20/2000 | EP0854883A4 Developmentally-regulated endothelial cell locus-1 |
| 09/20/2000 | EP0766735B1 Class bi and ci scavenger receptors |
| 09/20/2000 | EP0764030B1 Composition containing autoantibodies for tumor therapy and prophylaxis |
| 09/20/2000 | EP0623216B1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS |
| 09/20/2000 | EP0586549B1 Selecting ligand agonists and antagonists |
| 09/20/2000 | EP0504327B1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
| 09/20/2000 | CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b |
| 09/20/2000 | CN1266902A Human membrane translocator and its coding sequence |
| 09/20/2000 | CN1266901A I-type isomer of human steroid 5 alpha reductase and its coding sequence |
| 09/20/2000 | CN1266899A Precursor heteromorphic protein of human calcium binding protein and its coding sequence |
| 09/20/2000 | CN1266898A Human carboxypeptidase precursor protein and its coding sequence |
| 09/20/2000 | CN1266854A Application of specific antibody in preparing food to prevent digestive tract diseases |
| 09/20/2000 | CN1266714A Humanized antibody |
| 09/20/2000 | CN1056647C Production of immunoproximity catalysts |
| 09/19/2000 | US6121428 Protein recovery |
| 09/19/2000 | US6121427 Major outer membrane protein CD of branhamella |
| 09/19/2000 | US6121424 Immunogen association polypeptides with at least two preferences; for the delivery of cells, cytotoxins, or drugs to preferential positioning |
| 09/19/2000 | US6121423 Polypeptide light chain of an immunoglobulin; for the treatment and prevention of autoimmune diseases, glomerulonephritis and myelomas; antitumor agents |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121233 Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121230 Administering polypeptide acting as vascular endothelial growth factor antagonist to treat and/or prevent endometriosis |
| 09/19/2000 | US6121035 Amino acid sequences; for screening drugs and producing antibodies |
| 09/19/2000 | US6121030 CSAPK-2 protein and uses therefor |
| 09/19/2000 | US6121022 Nucleic acid encoding a modified polypeptide including an immunoglobulin or immunoglobulin-like constant domain and a salvage receptor binding epitope within the domain; for treatment and detection of various diseases |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6121004 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 09/19/2000 | US6121003 Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use |
| 09/19/2000 | US6120989 Isolated human cytomegalovirus polypeptides and uses thereof |
| 09/19/2000 | US6120988 Method of detecting hev infection |
| 09/19/2000 | US6120777 High fluorescence specific immune enhancing factor and methods of use for same |
| 09/19/2000 | US6120769 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 09/19/2000 | US6120767 Genetic engineering |
| 09/19/2000 | US6120766 CDW52-specific antibody for treatment of multiple sclerosis |
| 09/19/2000 | CA2046188C Kit for the specific assay of angiotensin ii |
| 09/14/2000 | WO2000054057A1 Selection of intracellular immunoglobulins |
| 09/14/2000 | WO2000053790A1 Target cell-specific, multivalent proteins (mvp) |
| 09/14/2000 | WO2000053776A2 Human kallikrein-like genes |
| 09/14/2000 | WO2000053758A2 Compositions and methods for the treatment of immune related diseases |
| 09/14/2000 | WO2000053757A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053756A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/14/2000 | WO2000053755A2 Compositions and methods for the treatment of tumor |
| 09/14/2000 | WO2000053754A1 Compositions and methods for the treatment of tumor |
| 09/14/2000 | WO2000053753A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053752A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/14/2000 | WO2000053751A1 Methods and compositions for inhibiting neoplastic cell growth |
| 09/14/2000 | WO2000053750A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | WO2000053749A2 Vascular adhesion molecules and modulation of their function |
| 09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | WO2000053634A1 Single-stranded fv inducing apoptosis |
| 09/14/2000 | WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
| 09/14/2000 | WO2000053631A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
| 09/14/2000 | WO2000053623A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000053223A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | WO2000053218A1 Neurodegenerative disorder related gene |
| 09/14/2000 | WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 09/14/2000 | WO2000053215A2 Deglycosylated ricin toxin a-chain vaccine |
| 09/14/2000 | WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
| 09/14/2000 | WO2000037102A3 Improvement of tolerance to a xenograft |
| 09/14/2000 | WO2000035409A3 Hiv-i fusion inhibition compounds |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
| 09/14/2000 | WO2000025812A3 Method for preparing solid phase conjugate vaccines |
| 09/14/2000 | WO2000023588B1 G-protein coupled receptors |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 09/14/2000 | DE19910159A1 Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung Specific IgY-egg yolk, their production and their use |
| 09/14/2000 | CA2478736A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478730A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2478728A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
| 09/14/2000 | CA2367315A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | CA2366713A1 Antibody and chemokine constructs and their use in the treatment of autoimmune diseases |
| 09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
| 09/14/2000 | CA2366689A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | CA2366147A1 Casb618 polynucleotides and polypeptides and their use |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
| 09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
| 09/14/2000 | CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 09/14/2000 | CA2362885A1 Human kallikrein-like genes |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362427A1 Compositions and methods for the treatment of immune related diseases |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |